Healthy elderly people who begin reporting memory lapses are significantly more likely to be diagnosed with dementia roughly a decade later, according to a study published online Sept. 24 in Neurology.
A new blood test said to predict Alzheimer’s disease up to 10 years before its onset will be available to researchers and pharmaceutical companies this fall, according to NanoSomiX, the company that developed it.
Benzodiazepine use is associated with an increased risk of Alzheimer's disease, with exposure density correlating with increased strength of association, according to a study published online Sept. 9 in BMJ.
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
Cerebrospinal fluid biomarkers for Alzheimer's disease, particularly β-amyloid 42 (Aβ42), are strongly associated with AD diagnosis, independent of APOE genotype, according to a study published online Aug. 27 in JAMA Psychiatry.
Researchers have manufactured a peptide aimed to block modified proteins associated with Alzheimer’s disease, Parkinson’s disease, heart disease, type 2 diabetes, Lou Gehrig’s disease, and other conditions.